Drug Patents owned by Glaxosmithkline Cons
1. List of Flonase Sensimist Allergy Relief drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9320862 | GLAXOSMITHKLINE CONS | Fluid dispensing device |
Nov, 2024
(1 year, 8 months from now) | |
| US8752543 | GLAXOSMITHKLINE CONS | Fluid dispensing device |
Apr, 2026
(3 years from now) | |
| US8062264 | GLAXOSMITHKLINE CONS | Fluid dispensing device |
Apr, 2026
(3 years from now) | |
| US8347879 | GLAXOSMITHKLINE CONS | Fluid dispensing device |
Jul, 2028
(5 years from now) | |
| US8147461 | GLAXOSMITHKLINE CONS | Fluid dispensing device |
Oct, 2028
(5 years from now) | |
Drugs and Companies using FLUTICASONE FUROATE ingredient
Market Authorisation Date: 02 August, 2016
Treatment: NA
Dosage: SPRAY, METERED;NASAL
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic